Atenolol/Chlorthalidone [Regulatives / Guidelines]

posted by Dr_Dan  – Germany, 2013-12-19 12:08 (4570 d 18:37 ago) – Posting: # 12077
Views: 5,392

Dear Amr Hussein
Do you have a fixed dose combination? If yes then it will not be possible to perform an in-vitro biowaver for Atenolol and demonstrate bioequivalence for chlorthalidone by means of an in-vivo study. Both components of the drug product need to be evaluated regarding their bioavailability in one and the same comperative bioavailability study.
If you are talking about two different products then you can request for biowaver of Atenolol and perform a bioequivalence study for chlorthalidone.
I hope this helps
Kind regards
Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
127 visitors (0 registered, 127 guests [including 14 identified bots]).
Forum time: 07:46 CEST (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5